These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38704079)

  • 1. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells.
    Li J; Lin W; Huang T; Chen M; Lin Q
    Exp Cell Res; 2024 Jun; 439(1):114073. PubMed ID: 38704079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
    Huang F; Wan J; Hu W; Hao S
    Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells.
    Sun JC; Pan K; Chen MS; Wang QJ; Wang H; Ma HQ; Li YQ; Liang XT; Li JJ; Zhao JJ; Chen YB; Pang XH; Liu WL; Cao Y; Guan XY; Lian QZ; Xia JC
    Cancer Biol Ther; 2010 Aug; 10(4):368-75. PubMed ID: 20581468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
    Su H; Li B; Zheng L; Wang H; Zhang L
    Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
    Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
    Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
    Zuo B; Qi H; Lu Z; Chen L; Sun B; Yang R; Zhang Y; Liu Z; Gao X; You A; Wu L; Jing R; Zhou Q; Yin H
    Nat Commun; 2020 Apr; 11(1):1790. PubMed ID: 32286296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Exp Med; 2018 Nov; 18(4):535-546. PubMed ID: 30062618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma.
    Chang C; Pei Y; Zhang C; Zhang W; Qin Y; Shi S
    Cancer Immunol Immunother; 2023 Nov; 72(11):3727-3738. PubMed ID: 37665374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-derived exosomes function as tumor antigens in patients with advanced hepatocellular carcinoma.
    Shi S; Wang L; Wang C; Xu J; Niu Z
    Mol Immunol; 2021 Jun; 134():210-217. PubMed ID: 33819783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
    Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.
    Pan K; Zhao JJ; Wang H; Li JJ; Liang XT; Sun JC; Chen YB; Ma HQ; Liu Q; Xia JC
    Int J Biol Sci; 2010 Oct; 6(7):639-48. PubMed ID: 20975822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.
    Yang M; Zhang Z; Chen J; Xu M; Huang J; Wang M; Li W; Wan X; Yuen MF; Luo X; Xi D; Ning Q
    J Exp Clin Cancer Res; 2019 Aug; 38(1):351. PubMed ID: 31409352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes derived from Rab27a‑overexpressing tumor cells elicit efficient induction of antitumor immunity.
    Li W; Mu D; Tian F; Hu Y; Jiang T; Han Y; Chen J; Han G; Li X
    Mol Med Rep; 2013 Dec; 8(6):1876-82. PubMed ID: 24146068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.